Perth Health Professionals Dinner and Webinar: CAR T-Cell Therapy and the Rural Patient

We’re excited to invite you to our upcoming hybrid lymphoma education dinner.

Join us either In-Person in the Murray Room for dinner at QT Hotel Perth, or Online via the Webinar Link, to learn about the latest updates in:

CAR-T Cell Therapy
Nursing Management
Considerations for Rural Patients and
Emerging Toxicities

Guest Speakers

Dr Allison Barraclough: Haematologist
Lymphoma Lead and CAR-T Program Director at Fiona Stanley Hospital, Perth WA. Dr Barraclough has a special interest in immunological treatments for lymphoma and in supporting patients in rural and remote areas living with haematological malignancies.

Helena Furdas: Nurse Practitioner

Helena graduated from Curtin University in 2009 and began her career in haematology at Royal Perth Hospital in 2010. Since then she has immersed herself in all aspects of malignant haematology and followed the state stem cell transplant service to Fiona Stanley Hospital in 2015. In 2020. Helena transitioned to Sir Charles Gairdner Hospital to establish the Lymphoma Clinical Nurse Consultant position and has been hooked on lymphoma ever since. After earning her Master’s Degree from Monash University in 2023, Helena has recently progressed to the role of Lymphoma Nurse Practitioner. She is passionate about providing clinical expertise to individuals living with lymphoma and can often be found lying on the beach with her dog, no matter the weather.

Join us in-person in Perth, or online, for an informative and inspiring evening focused on lymphoma care, connection, and community.

Register today to secure your spot.

Agenda

ARRIVAL	6pm	Welcome
Welcome	615-630pm	Welcome Address by Kimberley McKinnon: Lymphoma Care Nurse
Presentation 1	630-715pm	Dr. Allison Barraclough, Haematologist: CAR T-Cell Therapy for the Rural, Regional, and Remote patient
Presentation 2	745-830pm	Helena Furdas, NP: Nursing Considerations and Toxicity Management of the Rural Patient
Networking	830-845pm	Networking
MEETING CLOSE	9pm	Safe Travels Home

Dinner Location

There is limited availability for this event, so secure your spot quickly.

This event has already taken place.

Details

Date: Monday 27th of October 2025

Time: 6:00pm AWST - 9:00pm AWST

Location: QT Perth
133 Murray Street, Perth WA 6000

Support and information

Patient Online Forum

Find Out More

Order Our Resources

Find Out More

Fundraise for us

Get started

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
Relapsed: This means the lymphoma came back after being gone for a while after treatment.
2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here.

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.